Incannex Healthcare (IXHL) Gains from Investment Securities (2024 - 2026)

Incannex Healthcare (IXHL) has reported Gains from Investment Securities for 3 consecutive years, with -$380000.0 the latest figure, recorded in Q1 2026.

• Quarterly Gains from Investment Securities rose 79.17% year-over-year to -$380000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (changed N/A YoY) and the FY2025 annual result came in at $21.9 million, changed N/A from the prior year.
• Gains from Investment Securities retreated to -$380000.0 in Q1 2026 per IXHL's latest filing, from $23.6 million in the prior quarter.
• Over the last five years, Gains from Investment Securities for IXHL reached as high as $23.6 million in Q2 2025 and fell as low as -$1.8 million in Q1 2025.
• A 3-year average of $5.4 million and a median of -$138500.0 in 2024 frame the typical range for Gains from Investment Securities.
• The largest YoY upside for Gains from Investment Securities was 79.17% in 2026 against a maximum downside of 79.17% in 2026.
• Year by year, Gains from Investment Securities stood at $103000.0 in 2024, then soared by 22857.28% to $23.6 million in 2025, then tumbled by 101.61% to -$380000.0 in 2026.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$380000.0, $23.6 million, and -$1.8 million for Q1 2026, Q2 2025, and Q1 2025 respectively.